A double-blind, placebo controlled study to assess the safety and preliminary efficacy of PSD506 in treatment-naive or previously treated (washed out) patients with symptoms of overactive bladder (OAB)

Trial Profile

A double-blind, placebo controlled study to assess the safety and preliminary efficacy of PSD506 in treatment-naive or previously treated (washed out) patients with symptoms of overactive bladder (OAB)

Completed
Phase of Trial: Phase II

Latest Information Update: 24 May 2017

At a glance

  • Drugs PSD 506 (Primary)
  • Indications Overactive bladder
  • Focus Adverse reactions; Pharmacokinetics; Therapeutic Use
  • Sponsors Plethora Solutions
  • Most Recent Events

    • 07 Jul 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top